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The Journal of Immunology
Pig Bone Marrow-Derived Macrophages Resemble Human
Macrophages in Their Response to Bacterial
Lipopolysaccharide
Ronan Kapetanovic,* Lynsey Fairbairn,* Dario Beraldi,* David P. Sester,† Alan L. Archibald,*
Christopher K. Tuggle,‡ and David A. Hume*
Mouse bone marrow-derived macrophages (BMDM) grown in M-CSF (CSF-1) have been used widely in studies of macrophage
biology and the response to TLR agonists.We investigated whether similar cells could be derived from the domestic pig using human
rCSF-1 and whether porcine macrophages might represent a better model of human macrophage biology. Cultivation of pig bone
marrow cells for 5–7 d in presence of human rCSF-1 generated a pure population of BMDM that expressed the usual macrophage
markers (CD14, CD16, and CD172a), were potent phagocytic cells, and produced TNF in response to LPS. Pig BMDM could be
generated from bone marrow cells that had been stored frozen and thawed so that multiple experiments can be performed on
samples from a single animal. Gene expression in pig BMDM from outbred animals responding to LPS was profiled using
Affymetrix microarrays. The temporal cascade of inducible and repressible genes more closely resembled the known responses
of human than mouse macrophages, sharing with humans the regulation of genes involved in tryptophan metabolism (IDO, KYN),
lymphoattractant chemokines (CCL20, CXCL9, CXCL11, CXCL13), and the vitamin D3-converting enzyme, Cyp27B1. Con-
versely, in common with published studies of human macrophages, pig BMDM did not strongly induce genes involved in arginine
metabolism, nor did they produce NO. These results establish pig BMDM as an alternative tractable model for the study of
macrophage transcriptional control. The Journal of Immunology, 2012, 188: 3382–3394.
C
ells of the mononuclear phagocyte system, including
monocytes, bone marrow progenitor, and tissue macro-
phages and dendritic cells (1–3), are the first line of de-
fense against potential pathogens and have numerous trophic roles
in development and homeostasis (4). These cells comprise 10–
15% of the total cells in most organs of the body, and are espe-
cially concentrated adjacent to mucosal surfaces (5). Their dif-
ferentiation and maturation are controlled by hemopoietic growth
factors, notably CSF-1 and IL-34, which share a receptor encoded
by the c-fms protooncogene (6, 7).
Upon recognition of a potential pathogen, resident macrophages
within tissues initiate an early inflammation response that leads
to recruitment of neutrophils and inflammatory monocytes (8).
Recognition is mediated through pattern recognition receptors that
bind to pathogen-associated molecules. The archetypal pattern
recognition receptor is TLR4, which, with the coreceptor MD-2,
recognizes LPS, a component of the cell wall of Gram-negative
organisms (9). TLR4/MD2 ligation induces the recruitment of
multiple adaptors interacting though their Toll/IL-1R domain. One
pathway, requiring the adaptors MyD88 and TIRAP/Mal leads to
translocation of NF-kB and transcription of proinflammatory
cytokines. A second, initiated following endocytosis, and involv-
ing TRAM, activates IFN regulatory factor (IRF) 3 and leads to
type 1 IFN induction (9). The regulatory cascade initiated fol-
lowing TLR4 ligation involves regulation of thousands of tran-
scripts, with sequential induction and repression of numerous
transcriptional regulators generating a complex network (10–13).
Appropriate regulation of this cascade determines the outcome
of infection, because many of the induced genes are required
for defense against the pathogen, but also causes much of the
pathology. Feedback control by numerous negative regulators
is needed to ensure that the response is limited and appropriate
(14, 15).
Many studies of LPS signaling have been carried out using
murine bone marrow-derived macrophages (BMDM): cells grown
from bone marrow in the presence of M-CSF (CSF-1) (16). CSF-1
is required for the maintenance of macromolecule synthesis and
ultimately for survival of macrophages. It regulates the expression
of the TLRs in mouse macrophages, and alters the response to
LPS (17). Conversely, one of the earliest detected responses to
TLRs is downregulation of the CSF-1 receptor and growth arrest
(18), and a subset of genes is induced solely as a consequence of
the removal of the CSF-1 signal (19).
Most of our knowledge of TLR signaling derives from studies
of the mouse, taking advantage of knockout technology to define
the roles of specific signaling molecules. However, CSF-1 signals
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rather differently in humans than in mice (20); numerous differ-
ences have been observed in the responses of the two species to
LPS and the sets of innate immune effectors (21). The immunity-
related GTPase family provides one example, as follows: mice
possess 23 different members, whereas only one can be found in
humans (22). Another important example is the regulation of in-
ducible NO synthetase (NO synthase 2 [NOS2]). By contrast to
mice, human macrophages in vitro do not upregulate arginine
metabolism to produce NO in response to LPS, but instead me-
tabolize tryptophan via IDO (23).
We recently reviewed the differences between mouse and hu-
man inflammatory biology in the context of consideration of the
domestic pig as an alternative model (21). The comparison is
somewhat compromised by the use of distinct populations of
cells. Most human studies employ monocyte-derived macrophages
grown in CSF-1 (24). Mouse monocytes are not readily accessed
in substantial numbers and may differ from humans in terms of
their maturation state/subpopulations (25) and in their response to
inflammatory stimulus like LPS (26). Conversely, access to human
bone marrow is also not straightforward, and human BMDM have
not been reported. We therefore decided to bridge the mouse and
human systems by studying BMDM from pigs. Pigs are eco-
nomically important in their own right, and are susceptible to
many viral and bacterial pathogens that can also infect humans, or
that cause similar pathologies to human infections (27, 28). So,
there is the reciprocal interest in whether humans or mice provide
an adequate model for pig innate immunity. The tractability of
the pig as an experimental model is enhanced greatly by the
impending completion of a high quality genomic sequence (29).
Previous work demonstrated that pig bone marrow cultured in
L929-conditioned medium (a source of mouse CSF-1) and horse
serum generated cells with the morphological and functional
characteristics of macrophages (30). In the current study, we have
established a system for generating BMDM from the pig using
human rCSF-1 (rhCSF-1) and FCS, the same reagents used in
mouse and human studies. We used this system to determine the
time course of regulation of gene expression in response to LPS
and the variation among individual animals. The results indicate
that pig BMDM resemble human monocyte-derived macrophages
in their response to LPS and could provide a better predictive
model for testing candidate therapeutic approaches in sepsis and
other infectious pathologies.
Materials and Methods
Animals
Male Large White or F1 cross Large White-Landrace pigs of 8–12 wk of
age were used, as indicated. All the pigs spent at least 2 wk in the same
facility before experimentation. All animal care and experimentation was
conducted in accordance with guidelines of Roslin Institute and the Uni-
versity of Edinburgh and under Home Office Project License PPL 60/4259.
Cell isolation and culture
Pigs were sedated with a mixture of ketamine (6 mg/kg) and azaperone (1
mg/kg), left undisturbed for a minimum of 15 min, and then killed by
captive bolt. Five posterior ribs from each side of the animal were removed.
The outer surface of the bone was cleaned with alcohol, both extremities
were cut, and, using a 20-ml syringe with an 18-g needle, bone marrow was
flushed from both ends with RPMI 1640 (Sigma-Aldrich) containing 5 mM
EDTA to prevent clotting. Cells were spun, suspended in red cell lysis buffer
(10 mM KHCO3, 150 mM NH4Cl, 0.1 mM EDTA [pH 8.0]) for 2 min,
spun again, and washed with PBS, followed by RPMI 1640. Bone marrow
cells were finally suspended in a freezing medium (90% heat-inactivated
FCS-10% DMSO) and frozen overnight in a “Mr. Frosty” isopropanol box
at 280˚C (Nalgene), allowing a controlled decrease of temperature. The
next day, cells were transferred to a 2150˚C freezer for long-term storage.
To recover cells from the freezer, they were thawed rapidly in a 37˚C
waterbath, then slowly diluted by dropwise addition of complete medium
over 2–3 min to avoid the shock of sudden dilution of DMSO. After be-
ing washed to remove DMSO, cells were cultured in complete medium-
RPMI 1640, 10% heat-inactivated FCS (PAA Laboratories), penicillin/
streptomycin (15140; Invitrogen, Paisley, U.K.), and GlutaMAX-I sup-
plement (35050-61; Invitrogen). BMDM were obtained by culturing bone
marrow cells for 5–7 d in presence of rhCSF-1 (104 U/ml; a gift of Chiron,
Emeryville, CA) on 100-mm2 sterile petri dishes, essentially as described
previously for the mouse (18). The resulting macrophages were detached
by vigorous squirting with medium using a syringe and 18-g needle,
washed, counted, and seeded in tissue culture plates at 106 cells/ml in CSF-
1–containing medium. The cells were treated where appropriate with LPS
from Salmonella enterica serotype minnesota Re 595 (L9764; Sigma-
Aldrich) at a final concentration of 100 ng/ml.
ELISA
TNF was measured in culture supernatants by ELISA, as specified by the
manufacturer (DuoSet; R&D Systems, Minneapolis, MN). Nitrite (the
product of rapid NO oxidation in culture) concentration was measured
by Griess assay [1% sulfanilamide, 0.1% N-(1-naphtyl) ethylenediamine
diHCl, 2.1% phosphoric acid], using sodium nitrite standards (Flucka
Analytical). Samples were diluted 1/2 with RPMI 1640, and an equal
volume of Griess reagent was added. Absorbance was measured at 540 nm.
Flow cytometry
Cells were incubated 15 min with high-blocking solution (PBS, 0.1%
sodium azide, 2% FCS, 0.1% BSA), and then washed with low-blocking
solution (PBS, 0.1% sodium azide, 0.2% FCS, 0.1% BSA). Cells were
stained with either a mouse anti-pig CD14 Ab (clone MCA1218, 1:50;
AbD Serotec), a mouse anti-pig CD16 Ab (clone MCA1218, 1:200;
AbD Serotec), a mouse anti-pig CD163 Ab (clone MCA1218, 1:200; AbD
Serotec), a mouse anti-pig CD172a Ab (clone MCA1218, 1:400; AbD
Serotec), or an IgG2b or IgG1 isotype control (MCA691 and MCA928PE;
AbD Serotec; same concentration as primary Ab) in Low Block. The cells
were then washed and resuspended in 500 ml Low Block. Data were ac-
quired on 50,000 cells using a CyAn ADP Analyzer (Beckman Coulter,
High Wycombe, U.K.) and analyzed with Summit software (v4.3).
Phagocytosis assay
Cells were plated either on acid-washed glass coverslips (fluorescence
microscopy) or 24-well plates (flow cytometry) and cultured overnight.
Phagocytosis was initiated by centrifugation (600 3 g, 1 min) of FITC-
conjugated zymosan bioparticles (Molecular Probes) at a particle:cell ratio
of ∼10:1, followed by incubation at 37˚C/5% CO2.
For fluorescence microscopy, coverslips were washed with ice-cold
PBS/0.1% sodium azide 5 min for a total of six times, fixed with 4%
paraformaldehyde/PBS for 10 min, followed by an additional four washes
with PBS. Cells were then permeabilized with 1% Triton X-100 for 5 min,
followed by four 5-min washes with PBS. Cells were blocked with PBS/1%
BSA for 1 h, and then stained for 30min with a 1/100 dilution of Alexa Fluor
546-conjugated phalloidin (Molecular Probes) in PBS/0.2% BSA. Cover-
slips underwent three additional 5-min washes with PBS, a rapid wash in
milliQ water, followed by mounting using VECTASHIELD Mounting
Medium with DAPI (Vector Laboratories, Peterborough, U.K.).
MTT assay of viable cells
Mouse and pig BMDM (2 3 104 cells) were seeded in 100 ml complete
medium, in a 96-well plate with or without rhCSF-1 (104 U/ml). Every
24 h, 10 ml 5 mg/ml MTT (Sigma-Aldrich) was added in the culture for
2.5 h at 37˚C. Medium was then homogenized by adding 100 ml solubi-
lization buffer (0.1 M HCl-10% Triton isopropanol) and left overnight at
37˚C. OD was read the next day at 540 nm.
Microarray-RNA preparation
To investigate the macrophage response to LPS, BMDM extracted from
three pigs (one female, two males, F1 cross Landrace 3 Large White; see
above) were cultured 1 wk in medium (RPMI 1640, 10% FCS, penicillin/
streptomycin, GlutaMAX-I) in presence of rhCSF-1 (104 U/ml). Cells were
then harvested and plated in 6-well plates at a concentration of 106 cells/ml
and left to rest overnight. The next day, BMDM were stimulated with LPS
(100 ng/ml). RNA for gene expression analysis was collected at time
points 0, 2, 7, and 24 h post-LPS stimulation. Each time point included
BMDM from the same three pigs, and each cell culture was replicated.
Therefore, a total of 24 microarrays was hybridized (four time points, three
pigs, two cell culture replicates). For further analyses, the two replicates
of each cell culture were averaged. We detected probes differentially
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expressed between time point 0 (unstimulated macrophages) and each of
the other time points by fitting a linear model through each probe set using
the Bioconductor package LIMMA. The design matrix for the linear
models included a coefficient for each of the three pigs and a coefficient for
the comparisons of interest, as follows: 0 versus 2 h, 0 versus 7 h, and
0 versus 24 h. RNAwas extracted from BMDM using the Qiagen RNeasy
kit, as specified by the manufacturer (Qiagen, Crawley, U.K.). RNA con-
centration was measured using ND-1000 Nanodrop (Thermo Scientific).
The quality was controlled by running the samples on the RNA 6000
LabChip kit (Agilent Technologies, Waldbronn, Germany) with the Agi-
lent 2100 bioanalyzer in which samples are assigned an integrity clas-
sification from 10 (intact RNA) to 1 (highly degraded) by the 2100
bioanalyzer expert software. RNA used for the microarray had a concen-
tration between 30 and 539 ng/ml (mean = 257, SD = 126). RNA integrity
number ranged from 9.70 to 10 (mean = 9.96, SD = 0.02). Total RNAwas
prepared for hybridization using the Affymetrix 39 IVT Express kit
(Affymetrix, Santa Clara, CA), following the manufacturer’s instructions,
and hybridized to the Affymetrix GeneChip Porcine Genome Array in-
cluding 24,123 probe sets by ARK-Genomics (http://www.ark-genomics.
org). Probe set expressions were normalized using the RMA algorithm
(31), as implemented in the Bioconductor package affy (32, 33). The an-
notation of the genes was based upon an update of the Affymetrix porcine
annotation, in part upon cross-mapping of Affymetrix human annotation,
as described (34); the updated annotation is available at http://www.
anexdb.org.
Normalized array data were uploaded to the software Biolayout Express
(3D) (http://www.biolayout.org/) (35), and a graph was created using
parameters of R mean 0.95, Markov clustering algorithm of 2.2, and
a minimum number of 6 nodes per cluster (36).
RT-PCR
cDNA was synthesized from 1 mg RNA using Superscript III (Invitrogen,
Carlsbad, CA), and mRNA expression was quantitated using the SYBR
Green quantitative PCR system (Invitrogen). All oligonucleotides were
designed using Primer3 (37) and synthesized by Invitrogen (Paisley, U.K.).
Primers were designed with an optimal amplicon size between 80 and 150
bp. Primer pairs were designed so that one of the primers overlapped an
exon junction to prevent possible amplification of any remaining genomic
DNA. Primers are designed with an annealing temperature of 60˚C and
optimized using a pool of cDNA consisting of the samples to be tested.
The dissociation curve analysis for each primer pair ensured that only
a single amplification product was produced and efficiency was between
95 and 105%. Primers were used at 500 nM, as follows: hypoxanthine
phosphoribosyltransferase (forward, 59-ACACTGGCAAAACAATGCAA-
39; reverse, 59-ACACTTCGAGGGGTCCTTTT-39), CCL20 (forward, 59-
GGTGCTGCTGCTCTACCTCT-39; reverse, 59-GCTGTGTGAAGCCC-
ATGATA-39), IDO1 (forward, 59-GGTTTCGCTATTGGTGGAAA-39; re-
verse, 59-CTTTTGCAAAGCATCCAGGT-39), STAT4 (forward, 59-GA-
AAGCCACCTTGGAGGAAT-39; reverse, 59-ACAACCGGCCTTTGTT-
GTAG-39), and NOS2 (forward, 59-CCACCAGACGAGCTTCTACC-39;
reverse, 59-TCCTTTGTTACCGCTTCCAC-39).
Promoter sequence alignment
All sequences have been extracted from the Ensembl database, and
alignment was performed using the software MacVector. The software
Alibaba2.1 was used to predict the most probable transcription factor
binding sites by constructing matrices on the fly from TRANSFAC 4.0 sites
(http://www.gene-regulation.com).
Results
A large number of cells can be obtained from a single pig and
give rise to macrophage-like cells in response to human CSF-1
In mice, bone marrow cells can be easily isolated from the femur of
the animal and differentiated into macrophages in response to
rhCSF-1 (38). Typically, cells from several mice are required for
a single experiment. However, mouse cells have been frozen and
recovered, expediting the study of knockout lines held by other
researchers (39). Clearly, many more cells can be generated from
a pig, so to avoid unnecessary animal use, we optimized a freezing
protocol. Bone marrow cells were isolated by flushing 10 poste-
rior ribs of each pig. Approximately 109 cells were obtained rou-
tinely from a single animal and cryopreserved in a freezing me-
dium comprising 90% FCS and 10% DMSO at a temperature of
2155˚C. Following thawing, the percentage of viable cells was
∼80%. The early published study of pig BMDM (30) used femoral
marrow from piglets as the starting population, but this is im-
practical in older animals because of the adiposity of long bone
marrow. They added 30% L929 conditioned medium and 15%
horse serum and grew the cells in Teflon bags. The maximal cell
yield occurred after 10 d. Ribs provide a convenient alternative
source of marrow. Thawed cells cultured in the presence of
rhCSF-1 for 5–7 d on bacteriological plastic, the identical con-
ditions used for mouse BMDM, acquired a macrophage-like
morphology based upon an increase in size granularity and ad-
herence to the bacteriological plastic substratum (Fig. 1A, 1B).
Thus, we had a simple method for producing macrophages from
the pig that could be used to recover such cells for multiple
investigations sequentially from the same animal. The system is as
close as possible to that used in published studies of gene ex-
pression in mouse BMDM.
Pig BMDM display appropriate marker expression for
macrophage-like cells
Human blood monocytes can be subdivided into subpopulations
based upon the expression of CD14 and CD16 (40). We and others
have shown that pig monocytes can also be separated into sub-
populations that differ in their expression of CD16 and the scav-
enger receptor CD163 (21). As shown in Fig. 1, all pig BMDM
obtained following cultivation in rhCSF-1 expressed CD14, the
coreceptor for LPS. CD16, Fc receptor 3, was also expressed at
high levels on all cells, as was SCW3a and CD172 (SIRP a). The
pig BMDM had almost undetectable expression of CD163 and in
that respect resembled more mature pig (21) and human (41)
monocyte subsets.
Each of the positive markers was induced with time in culture of
bone marrow cells in CSF-1. Based upon the forward and side
scatter, the apparent granularity was retained, and cells became
significantly larger with time (Fig. 1C–E). CD14 was expressed on
a subset of the initial heterogeneous bone marrow cell population,
but increased substantially in both intensity and frequency with
time. CD163, also known as scavenger receptor cysteine-rich type
1 protein M130, was weakly expressed on some bone marrow
cells. CD16 and CD172a expression appeared rapidly on the cells
in the presence of CSF-1 (Fig. 1F–Q). Hence, we have a system in
which to study the differentiation of macrophage in the pig. With
the very large number of cells that can be obtained readily, this
system may lend itself to purification of progenitors and detailed
mechanistic studies.
Pig BMDM are potent phagocytic cells
The phagocytic activity of the pig BMDM was confirmed using
FITC-zymosan bioparticles (yeast cell wall component) (Supple-
mental Fig. 3). The majority of pig BMDM rapidly ingested
multiple particles. Similar results were observed with latex
microspheres (data not shown). In quantitative flow cytometric
assay, pig BMDM had comparable phagocytic ability to the murine
macrophage cell line RAW-264.7. By contrast, a nonphagocyte
control, pig fibroblasts, had no internalized particles.
Pig BMDM respond to LPS, but do not make NO
The main purpose for the generation of pig BMDMwas to examine
the response to LPS under similar conditions to those used in mouse
and human studies, to assess the evolutionary divergence in the
transcriptional regulatory cascade. Prior to a detailed examination
of the LPS response, we examined whether the cells were able to
produce the archetypal inflammatory cytokine, TNF-a. Secretion
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of TNF-a involves a multistep induction process including post-
translation cleavage of the protein from the cell surface by TNF-
a–converting enzyme (42, 43). As shown in Fig. 2A, TNF-a se-
cretion was induced in BMDM by LPS, reaching a peak after 10 h
of stimulation and then slowly decreasing. No TNF-a was de-
tected in the supernatant from unstimulated cells.
As noted in the introduction, mouse macrophages respond to
LPS with induction of arginine metabolism, inducible NO syn-
FIGURE 1. Characterization of pig BMDM. Bone marrow cells were isolated from pig ribs and cultured on bacteriological plastic in rhCSF-1. On day
0 (A), the cells were a mixture of small mononuclear cells and granular cells. After 7 d in rhCSF-1, the population was largely adherent and highly
vacuolated (B). Original magnification 3200. (C–E) The FACS profiles of granularity (side scatter y-axis) and cell size (forward light scatter x-axis) are
shown increasing as the cells mature in macrophages. At days 0, 3, and 7 of the maturation, expression of CD14 (F–H) was measured along with either
CD163, CD16, or CD172a (respectively, I–K, L–N, and O–Q). The color line represents the mean fluorescence intensity of the receptor targeted, whereas the
gray line represents the mean fluorescence intensity of the isotype control. Figures are representative of a minimum of three different experiments.
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thase, and production of NO, whereas human macrophages do not
(44, 45). One difficulty in comparisons of mouse and human has
been that comparisons are made between monocytes-macrophages
from different locations or differentiation states. Fig. 2B compares
mouse BMDM and pig BMDM, grown under identical condi-
tions in rhCSF-1. As expected, the LPS-stimulated mouse mac-
rophages produced large amounts of NO. By contrast, under the
same conditions, there was no detectable NO released from
stimulated pig BMDM. Benga et al. (46) have reported that pig
monocytes also do not produce NO in response to LPS.
By contrast to mouse cells, human macrophages respond to LPS
with induction of IDO (47). In a separate study, we confirmed two
other genes, the chemokine CCL20 (also known as MIP-3-a) and
the transcription factor STAT4, as being upregulated in human
monocyte-derived macrophages (K. Schroder, K.M. Irvine, M.S.
Taylor, N.J. Bokil, K.-A. Le Cao, K.-A. Masterman, L.I. Labzin,
C.A. Semple, R. Kapetanovic, L. Fairbairn, et al., submitted for
publication) (24), but not in mouse in response to LPS (http://
www.BioGPS.org) (10). The lack of induction of these genes in
mouse BMDM responding to LPS is also evident from genome-
scale 59RACE (CAGE) expression profile in the FANTOM project
(2) and in expression profiling of the RAW264 macrophage cell
line (48). We therefore investigated the expression of these four
genes (IDO1, NOS2, CCL20, and STAT4) in porcine BMDM after
LPS stimulation using quantitative RT-PCR (qRT-PCR) (Fig. 3).
IDO1 expression was massively upregulated after 6 h and slowly
decreased by 24 h. The levels of CCL20 and STAT4 mRNA were
also substantially elevated after LPS stimulation, continuing to
increase up to 24 h. We did not detect any expression of NOS2
mRNA in pig BMDM, consistent with the absence of NO pro-
duction.
Expression of genes after LPS stimulation of pig BMDM, using
a microarray approach
Having established the viability of the pig BMDM model, and
confirmed that the pattern of gene induction resembled published
studies of human monocyte-derived macrophages, at least for a
limited set of index genes, we investigated the gene expression
profiles in the primary pig BMDM population when stimulated
with LPS. BMDM were produced from three individual (one fe-
male, two males) F1 cross Landrace 3 Large White pigs. Using
Affymetrix porcine microarrays, we have analyzed changes in
gene expression at the transcript level using RNA from across
a time course of activation (0, 2, 7, and 24 h) in response to LPS in
two experimental replicates. To verify the response of the BMDM
to LPS treatment in the same cells used for expression profiling,
TNF-a production was measured by ELISA in the supernatant. In
all three time courses, TNF-a mRNA reached a peak of expression
at 2 h after stimulation, whereas the TNF-a protein production
was maximal at 7 h, reaching a concentration close to 3000 pg/ml
for 106 cells/ml (Fig. 4A). As expected from studies in the mouse,
LPS stimulation of pig BMDM induced the expression of a very
large number of genes, 3343 probe sets corresponding to 2159
genes (Fig. 4B), peaking at 7 h with 70.3% of the total upregulated
genes (2340 probe sets corresponding to 1518 upregulated genes),
including numerous known LPS-responsive cytokines and che-
mokines. As observed in the mouse BMDM response (10), many
of the gene inductions were transient and there was a sequential
cascade. Thirty percent of the probe sets were upregulated only at
7 h, 25.7% were upregulated only at 24 h, and 26.4% stay up-
regulated between 7 and 24 h. In keeping with the view that
negative regulation and feedback control is a critical determinant
of the duration and magnitude of LPS responses (49), LPS stim-
ulation of pig BMDM triggered even more downregulation of
genes than upregulation (a total of 5721 downregulated probe
sets, corresponding to 4258 genes) (Fig. 4C). At 2 h, 14.3% of
the probe sets (609 genes) were already downregulated, including
the top downregulated Hairy/Enhancer of Split 1, a transcrip-
tional repressor/activator, the Growth-Arrest and DNA damage-
inducible gene a (GADD45A), and the oncogene MYC (fold of
0.13, 0.14, and 0.18, respectively, relative to 0 h). The 25 most up-
and downregulated genes, with their fold increase, have been
provided (Supplemental Fig. 1).
Fig. 4D shows the histograms of the number of probes signif-
icantly affected by the LPS treatment at each of the three time
points. The 2-h time point produced a relatively small number of
probes affected by LPS (as shown also in Fig. 4C), but the ma-
FIGURE 2. Pig BMDM produce TNF-a, but
not NO, in response to LPS. (A) BMDM were
incubated with LPS for the time indicated, and
TNF-a protein was measured in the supernatant
by ELISA. (B) NO production was measured in
supernatant from pig and mouse BMDM stimu-
lated with LPS for 24 h. In each panel, the results
represent the mean 6 SEM of a minimum of five
independent experiments.
FIGURE 3. Pig BMDM expression of IDO1, CCL20, STAT4, and
NOS2. Pig BMDM were stimulated with LPS, as described in Materials
and Methods, for 2, 6, and 24 h. RNA expression of IDO1 (A), CCL20 (B),
STAT4 (C), and NOS2 (D) was measured by qRT-PCR. Results are
expressed as fold increase, normalized against the value for hypoxanthine
phosphoribosyltransferase. Results represent the mean 6 SEM of five in-
dependent experiments.
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jority of these genes were very highly regulated, and most genes
induced later in the regulatory cascade were induced, or repressed,
to a lesser extent. Among the 24,124 probe sets of the microarray,
a remarkable 15,450 were expressed at detectable levels, and, of
these, 11,819 showed a significantly different level of expression
between 0 and 2 h, 0 and 7 h, or 0 and 24 h. The data from the
microarray are published on the National Center for Biotechnol-
ogy Information Gene Expression Omnibus database (http://www.
ncbi.nlm.nih.gov; GSE30956), and are also available on http://
www.macrophages.com. As previously noted in studies of the
mouse (10, 12), gene induction follows a distinct temporal profile
with unique classes of genes induced maximally at each time
point. Numerous cytokine genes were upregulated shortly (2 h)
after LPS stimulation, including IL-1, TNF, IL-8, and IL-10. This
cluster did not include so-called immediate early response genes
such as c-fos and EGR1, which have been identified as LPS-
inducible genes in studies by one group (12), but not in data
from our laboratory (10) (biogps.gnf.org), in which LPS actually
represses c-fos. This difference arises from differences in the
experimental procedures; in our studies, we include CSF-1, which
is a considerably more effective inducer of early response genes
like c-fos than is LPS. Xie et al. (50) and Myers et al. (51) have
noted previously that LPS causes rapid growth arrest in mouse
BMDM. The latter authors noted a transient increase, followed by
repression of the proliferation-associated c-myc oncogene. In this
respect, the pig system clearly resembles the mouse (see above).
Similarly, and by contrast to the large induction of c-fos seen in
CSF-1–starved BMDM (12), Myers et al. (51) saw only a minor
increase in expression of c-fos mRNA above the CSF-1–induced
constitutive expression, followed by repression. We feel that re-
tention of CSF-1 is a more physiological model, because CSF-1 is
present constitutively in tissues and circulation (4). What is clear
from the findings is that immediately early gene induction, growth
repression, and inflammatory cytokine induction can be dissoci-
ated.
Supplemental Fig. 2 summarizes other known classes of genes
that are regulated in response to LPS. Upregulated genes include
many components of the TLR and other signaling pathways, in-
cluding multiple transcription factors as NF-kB1, the IRF family
(IRF1, 2, 3, 5, 7, 8, and 9), CEPBP-b and d, and PU-1, and co-
regulatory factors such as JMJD3, a demethylase 6B (52). As dis-
cussed by Wells et al. (14), we found that a major component of
the inducible genes comprises feedback repressors, including in-
hibitory transcription factors (NF-kBI) and corepressors (NCOR),
members of the suppressor of cytokine signaling family, dual
specificity phosphatase 1 (DUSP1/MKP1), ATF3, tristetraprolin,
also known as ZFP36, and several inhibitory cytokines (IL-1RA
also known as IL-1RN, TGF-b, and IL-10).
FIGURE 4. The mRNA expression
profile of pig BMDM stimulated with
LPS. BMDM from three individual
Large White-Landrace F1 cross pigs
were stimulated with LPS for 0, 2, 7,
and 24 h. (A) The expression of TNF-a
mRNA and protein measures by qRT-
PCR and ELISA, respectively, in the
cells used for expression profiling. (B
and C) The relative numbers of probe
sets up- and downregulated at a signi-
ficance threshold of p , 0.01 at each
of the time points. (D) The frequency
distribution of fold change (in base 2)
for the LPS-induced and LPS-repressed
probe sets at each time point. Note that
at the 2-h time point, there is a long tail
of very highly regulated genes.
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The software package Biolayout Express(3D) has previously
been used to analyze large data sets that included time course of
LPS stimulation in BMDM and thioglycolate-elicited peritoneal
macrophages (53, 54). The software allowed us to visualize the
entire data set as a network graph, and to identify sets of genes
that are robustly coexpressed across the three different animals
examined. The 24,124 (pig) probe sets were clustered using a
correlation of R = 0.95 and Markov clustering algorithm of 2.2,
generating 95 distinct clusters (Fig. 5A). The two largest clusters
are one group of downregulated genes and one group of upregu-
lated genes (Fig. 5B). The first cluster contains 226 different probe
sets downregulated, and cluster 2 contains a group of 209 probe
sets, all upregulated after LPS stimulation. A group of three
clusters shows a rapid upregulation after 2 h of LPS stimulation
and then a slow decrease in their expression (Fig. 5C, Table I).
This list includes the set of genes shown in the mouse system to
be induced at the level of transcription elongation, among which
the archetype is TNF-a (55). Many of these early response genes
initiate downstream signals, including IFN-b; IRF3, the IFN
regulator; IFNAR2, the receptor for IFN; and Jagged 1, a molecule
that is known to be a Notch ligand and a potential Th2-promoting
factor (56). Interestingly, GADD45B is also rapidly upregulated at
2 h. GADD45B has been shown to inhibit the apoptosis signal of
TNF-a by interfering with the JNK cascade (57). Upregulation of
GADD45B may then allow the macrophages to release TNF-a
without themselves undergoing apoptosis. A second cluster of
genes was not linked to the others and is composed of genes
quickly downregulated at 2 and 7 h, followed by a return to
normal expression at 24 h (Fig. 5D, Table II). Multiple genes of
this group have DNA-binding function, including CGC-binding
FIGURE 5. Network analysis of the response of pig BMDM to LPS using Biolayout(3D). (A) A network graphical representation of the pig macrophage
gene expression data in which genes with similar expression profiles are clustered together within the same region using the analytical tool Biolayout(3D).
This tool allows the visualization of the average expression profile of genes within a cluster across the data set. (B) Cluster 1 containing 226 probe sets
was repressed in all three animals (ss1, ss2, ss3) by 7 h; cluster 2 containing 209 probe sets was induced in all three animals, peaking at 7 h, but was
more rapidly repressed at 24 h in animal ss1. (C) Three clusters that show peak induction at 2 h. (D) Clusters in which the genes are transiently down-
regulated.
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protein 1, coiled-coil-helix-coiled-coil helix domain-containing 8,
or CCCTC-binding factor. This cluster also includes signaling
molecules, like MAPK 3 kinase 4 and the PI3K.
Using the expression data to identify unannotated genes highly
upregulated after LPS stimulation
Because a stable draft genome sequence for the pig is not yet
available for annotation, the array elements on the Porcine Gen-
eChip were annotated using RNA level comparisons to RefSeq
entries (34). The chip had a large number of unannotated probe
sets; the Affymetrix GeneChip information leaves 18,313 probe
sets unannotated. Using the ANEXdb (http://www.anexdb.org/),
we managed to lower this number down to 5,395 probe sets out of
24,123 (22.3%). But still, among these unannotated probe sets,
many were very highly regulated by LPS. To recover this infor-
mation, we blasted the probe set sequences of the 10 most in-
ducible genes against the human and pig genome. The revised
annotation revealed that CXCL11 (IFN-inducible T cell a che-
moattractant) was strongly upregulated at 7 h (388.5-fold), as well
as CD274 (programmed cell death ligand 1, 45-fold), alveolar
macrophage-derived chemotactic factor-II (42-fold), guanylate-
binding protein 2 (32-fold), DEAD box polypeptide 60 (22-
fold), and family with sequence similarity 49, member A (9.7-
fold). The data set will be further annotated after the completion
of the pig genome annotation effort.
Highlighting the similarity of pig and human macrophage LPS
response
CSF-1 primes mouse macrophages to respond to LPS with in-
creased TNF-a production, but CSF-1 pretreatment had no effect
on TNF-a in human monocyte-derived macrophages (58). As in
human macrophages, the presence or absence of CSF-1 for the
24 h prior to LPS stimulation did not significantly alter the TNF-a
production level in pig BMDM (Fig. 6A). As a control, we stim-
ulated mouse BMDM, and recapitulated the reported priming ef-
fect on TNF-a production (Fig. 6B). The lack of effects of
exogenous CSF-1 on TNF-a production by pig BMDM could be
explained by constitutive production of CSF-1 by pig BMDM. To
test this hypothesis, we cultured pig BMDM and mouse BMDM
for 4 d in the presence or absence of rhCSF-1 and measured cell
viability using the MTT assay. Mouse cells do not produce CSF-1
constitutively, and viability decreased rapidly following CSF-1
removal. Unlike mouse BMDM, pig BMDM did not undergo
cell death in the absence of rhCSF-1, although cellular meta-
bolic activity was increased when cultured with rhCSF-1 (Fig.
6C). We examined the expression of the three probe sets anno-
tated for CSF1 on the microarray and their specific targets on the
National Center for Biotechnology Information database. CSF1.1
(Ssc.19697.1.A1_at) targets the CSF1 gene on the wrong strand
and was not detected. Weakly expressed probe set CSF1.2
(Ssc.19697.1.S1_at) targets exons 4, 5, and 6, which encode the
transmembrane part of the protein. Finally, the strongly expressed
probe set CSF1.3 (Ssc.6369.1.A1_at) targets the 39 region of the
CSF1 gene. This region is contained in both membrane and se-
creted forms. Hence, the difference of expression between CSF1.2
and CSF1.3 suggests that pig BMDM produce a large amount of
mRNA encoding secreted CSF-1 constitutively (Fig. 6D).
Table I. Gene list of the three clusters (35, 51, and 93) showing an
upregulation peak at 2 h (linked to Fig. 5C) in pig BMDM responding to
LPS
Gene Full Name Cluster
CFLAR CASP8- and FADD-like apoptosis regulator 35
DPH3 DPH3 homolog 35
GADD45B Growth arrest and DNA damage-inducible
gene
35
GTPBP10 GTP-binding protein 10 35
IRF1 IFN regulatory factor 1 35
JUNB Oncogene JUN-B 35
PLTP Phospholipid transfer protein 35
SOCS3 Suppressor of cytokine signaling 3 35
BTG2 B cell translocation gene 2 51
DEPDC7 DEP domain-containing protein 7 51
FAM148B Nuclear localized factor 2 51
IER5 Immediate-early response gene 5 51
JAG1 JAGGED 1 51
RND3 RHO family GTPase 3 51
TNF TNF 51
IFNAR2 IFN a, b, and v receptor 2 93
RASSF2 RAS association domain family protein 2 93
SLC11A2 Solute carrier family 11, member 2 93
TNFAIP2 TNF-a–induced protein 2 93
UBTD2 Ubiquitin domain-containing protein 2 93
VHL VHL gene 93
Table II. Gene list of the two clusters (56 and 59) showing a rapid downregulation at 2 h in BMDM
stimulated with LPS, followed by a return to normal value at 24 h (linked to Fig. 5D)
Gene Full Name Cluster
AASDHPPT a-aminoadipate semialdehyde dehydrogenase-phosphopantetheinyl transferase 56
ADNP Activity-dependent neuroprotecto homeobox 56
CGGBP1 CGG-binding protein 1 56
CHCHD8 Coiled-coil-helix-coiled-coil-helix domain-containing protein 8 56
CTCF CCCTC-binding factor 56
MID1IP1 MID1-interacting protein 1 56
NAT12 N-acetyltransferase 12 56
NDUFS4 NADH-ubiquinone oxydoreductase Fe-S protein 4 56
RAB14 RAS-associated protein RAB14 56
SMAD2 SMA- and MAD-related protein 2 56
AOF2 Amine oxidase (flavin-containing) domain 2 59
C16orf53 PTIP-associated 1 protein 59
DCTN2 Dynactin 2 59
DVL2 Dishevelled 2 59
GFOD2 Glucose-fructose oxidoreductase domain containing 2 59
HHEX Hematopoietically expressed homeobox 59
MAP3K4 MAPK kinase kinase 4 59
PHF17 PHD finger protein 17 59
PIK3CG PI3K, catalytic, g 59
WHSC2 WHS candidate 2 gene (NELFA) 59
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The data already presented indicate that pig BMDM resemble
human macrophages in that they induced IDO, STAT4, and CCL20
in response to LPS, whereas these genes were unaffected in mouse
macrophages. Conversely, NOS2 was not inducible, nor was there
any production of NO. The metabolism of arginine in mouse
macrophages also involves induction of an arginine transporter
(SLC7A2 or CAT2), GTP cyclohydrolase (GCH1), and arginase
(ARG1 and ARG2). Of these, GCH1 and ARG2 were weakly
induced in pig BMDM at 2 h, respectively, with a fold of 2.29
(p = 0.0006) and 2.72 (p = 0.015), whereas the limiting arginine
transporter CAT2 was not detectable at any time.
To identify additional genes that distinguish pig from mouse
BMDM, we compiled a list of the 500 most induced probe sets
(comprising 174 gene names) in the pig BMDM at 7 h, and then
examined the regulation of these genes in mouse macrophages from
earlier studies now displayed on BioGPS (http://www.biogps.org)
and confirmed the lack of induction in other data sets from the
mouse (10, 59). From among this list, we identified 80 genes that
were detected in the mouse with multiple independent probe sets
(or CAGE Tags), but were not significantly regulated by LPS at
any time point. We compared the list of discordantly regulated
genes with the most similar human data set in the public domain
(GSE5099 and GSE8608) (24). Of those 80 genes, we found that
30 were highly induced in activated human monocyte-derived
macrophages (Fig. 7). Some of them are related to the IDO and
vitamin D3 pathway (KYNU and CYP27B1), active pathways in
humans, but not in mice. The heparin-binding epidermal growth
factor-like growth factor is also upregulated in humans and pigs,
but not in mice. Heparin-binding epidermal growth factor-like
growth factor is also known as the diphtheria toxin receptor,
and, interestingly, humans and pigs are sensitive to the toxin,
whereas mice are more resistant (60).
The genomic DNA sequence of the domestic pig is more similar
to the human than to the mouse; the exonic sequences are most
conserved across species, followed by 59 untranslated region
(UTR), 39UTR, intergenic, and intronic regions (61). To begin to
explain the concordance of pig and human inducible gene ex-
pression, we examined the sequence conservation of promoter
regions of divergently expressed genes across the three species.
One example, Cyp27B1, a gene upregulated in pigs and humans,
but not in mice, is shown in Fig. 8A. The protein product of this
gene is conserved 81% in mice and 87% in pigs (http://www.
ensembl.org), but the promoter region is considerably more di-
vergent between humans and mice. The divergence is highlighted
in Pustell DNA matrix alignment of the promoter region of
humans versus mice (Fig. 8B), compared with humans versus pigs
(Fig. 8C). In the latter case, there is a gap caused by a repeat
insertion in the pig, but otherwise, there is very substantial con-
servation extending almost 2 kb upstream. The conservation of
this 2-kb region is also seen in dogs and cattle, whereas rats, like
mice, are completely divergent (ecrbrowser.dcode.org). A detailed
ClustalW alignment shows subtle variation even in the proximal
promoter conserved across all three species. At270 bp (relative to
the start codon ATG), the TATA box sequence is identical in pig
and human, but varies from the consensus in mouse. At 2120 bp,
a consensus C/EBP binding site is found in all three species, but
FIGURE 6. Species-specific effect of CSF-1 on cell viability and responsiveness to LPS. Pig BMDM (A) or mouse BMDM (B) were incubated for 24 h
with or without rhCSF-1, and then stimulated with 100 ng/ml LPS. TNF-a protein was measured in the supernatant after an additional 24-h incubation. The
lines join pig or mouse BMDM from the same individual animal. Note that the priming effect of CSF-1 was significant in mouse (*), but not in pig BMDM .
(C) Mouse or pig BMDM at 2 3 105 cells/ml in RPMI 1640–10% FCS were incubated in 96-well plates for 4 d with or without 104 U/ml rHCSF-1 prior to
assay of viable cells based upon MTT reduction (see Materials and Methods). Medium-only background is shown at right. Note the decline in MTT
reduction in mouse BMDM in the absence of added CSF-1. (D) The expression of CSF-1 mRNA by pig BMDM. Expression of the three probe sets for
CSF1 was recovered from the array data above. Probe set CSF1.1 targets the opposite strand of CSF1 gene, whereas CSF1.3 targets the 39UTR common to
all forms of CSF-1.
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a NF-kB site at 2425 in the human is conserved in pig, but not in
mouse. We have carried out similar analyses of the divergently
regulated IDO1, CCL20, NOS2, STAT4, and IL-7R genes, in each
case highlighting the extensive similarities of the promoters of
these genes in pigs and humans (data not shown). It is especially
notable that the upstream enhancer region that mediates induction
of NOS2 in mouse macrophages, and which is poorly conserved in
humans (45), is absent in pigs (where the pig and human promoter
FIGURE 7. A set of genes induced by LPS in both pig and human macrophages, but not in mouse. The set of inducible genes for pig BMDM is derived
from the microarray data in Fig. 5, and shows the fold induction at 7 h. The expression for human monocyte-derived macrophages + LPS is derived from
published data sets (GSE5099 and GSE8608) and shows the maximal fold induction. Data for the mouse are derived from an analysis using Agilent custom
arrays (K. Schroder et al., submitted for publication). None of the genes shown was induced by LPS in either mouse BMDM or thioglycolate-elicited
peritoneal macrophages in a separate study using Affymetrix arrays (http://www.biogps.org), nor when expression was detected using genome-scale
59RACE or CAGE (2).
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regions are conserved). Furthermore, in the case of IL-7R, the
mouse promoter lacks the TATA box, which is conserved in pigs
and humans. TATA boxes are commonly associated with highly
regulated mammalian promoters (59).
Discussion
Marim et al. (62) reported that marrow cells from the mouse could
be cryopreserved for an extended period and still generate mac-
rophages. We have shown in this study that cells from pig marrow
could also be cryopreserved, thawed, and grown on bacteriological
plastic dishes to generate macrophages in response to rhCSF-1.
The pig BMDM were actively phagocytic, uniformly positive for
CD14, CD16, and CD172a, and responded to LPS with secretion
of the proinflammatory cytokine, TNF-a. As discussed recently
(26), mice have been studied extensively as a model for under-
standing human diseases, including sepsis, but they differ radically
from humans in their resilience in the face of endotoxemia. Quite
apart from the differences in sensitivity to LPS, mouse and human
macrophages differ in the set of genes that are induced upon ac-
tivation. These differences are not subtle differences in the mag-
nitude of induction; they are all or nothing. A striking example is
the production of NO in response to LPS. Human macrophages,
even when primed with IFN-g, do not induce NOS2, nor do they
regulate arginase or the arginine transporter (CAT2, Slc7a2)
(GSE5099) (24), found previously to be induced in mouse mac-
rophages (63). In most respects, the pig BMDM studied in this
work resembled human monocyte-derived macrophages more
closely than mouse BMDM. All three species induce the enzyme
GCH1, which generates the cofactor tetrahydrobiopterin (BH4),
and the by-product neopterin, which is a common marker of in-
flammation (64). Like human macrophages, and in keeping with
earlier findings on other pig macrophage populations, pig BMDM
did not produce NO, nor did they induce arginine-metabolizing
genes or CAT2 in response to LPS (44, 45). In addition, the re-
sponse of pig macrophages was unaffected by preincubation with
CSF-1 in common with human, and quite distinct from mouse
macrophages (58).
The microarray analysis revealed that approximately one-third
of the most regulated genes in pig BMDM were not found to be
induced in previous studies of mouse BMDM or other primary
macrophage populations (http://www.biogps.org). Of these, two-
thirds were previously found to be induced in activated human
monocyte-derived macrophages (GSE5099 and GSE8608). In ad-
dition to CCL20, which binds specifically to CCR6, and has been
implicated in homing of T cells and APCs (65), pigs shared with
humans the induction of CXCL13 and CXCL9, which are also
chemotactic for lymphocytes (66, 67). The most upregulated gene
at 7 h in the pig was CXCL11, an IFN-inducible T cell a che-
FIGURE 8. Divergence of the promoter sequence of the Cyp27B1 gene between humans, pigs, and mice. The 500-bp sequence upstream of the ATG of
the human and mouse cyp27B1 genes was extracted from ENSEMBL, or for the pig from the pre-ENSEMBL build. A Clustal W alignment of the three
sequences is shown in (A). A Pustell DNA matrix alignment of 2 kb upstream of the ATG between human and mouse promoter sequences (B) and between
humans and pigs (C) is shown below. Note the divergent sequence of the mouse around the TATA box and initiator region, and the upstream NF-kB motif.
The discontinuity in alignment of pigs and humans in (C) is due to a repeat insertion in human. All analysis used the MacVector package.
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moattractant (68). Induction of this set of chemokines suggests
that the pig and human responses to LPS could have a distinctive
engagement with the acquired immune system, a suggestion that
could also explain the shared expression of the IL-7R, because
IL-7 is associated with lymphoid development. In mice, IL-7R is
not induced by LPS, but it is expressed constitutively on inflam-
matory macrophages in the peritoneum (http://www.biogps.org). In
addition to IDO1, pig BMDM also share with human macrophages
the induction of other tryptophan pathway enzymes, kynurenine
hydoxylase, kynureninase, and tryptophan-tRNA synthetase. This
pathway is commonly referred to as IFN-g inducible (69), but
is clearly responsive to LPS alone in the pig BMDM. The path-
way generates a wide range of bioactive metabolites, including
hydroxykynurenine and various pteridines, quinolinic acid, and
3-hydroxy-anthranilate (69). Another well-known human-specific
inducible gene shared with pigs is CYP27B1, the enzyme that
generates active vitamin D. In humans, vitamin D has been im-
plicated in the control of antibacterial defense (70), and the vita-
min D receptor (VDR) is expressed constitutively by human
monocytes and macrophages, but not by mouse (http://www.
biogps.org). Others have reported that the VDR is expressed in
pig bone marrow (71). VDR is not annotated on our microarray,
but we have confirmed robust constitutive expression of VDR
mRNA in the pig BMDM by qRT-PCR (data not shown).
The segregation of the LPS-regulated genes into clusters of
genes with similar patterns of expression using Biolayout generated
95 distinct clusters. The distinctions arise because each gene has its
own distinct temporal profile of regulation, and some of them also
varied between the three animals and the biological replicates.
Genes that are subject to the same regulatory inputs and/or which
contribute to the same pathway tend to be stringently coregulated in
such a network. The genes that are induced rapidly by LPS, such as
TNF-a (cluster 51), include many of the so-called primary re-
sponse genes identified by Hargreaves et al. (55) that are bound by
preassembled RNApol II in the resting state and induced via
signal-dependent transcript elongation. A subset of these declines
rapidly from an initial peak, through mRNA degradation mediated
by the inducible RNA-binding protein tristetraprolin (72). Genes
that are induced maximally at 7 h, the secondary response genes,
include targets of inducible transcription factors, of which there
are at least 50 (73), including some that are shared by pigs and
humans, but not mice (STAT4, STAT1, IRF2, IRF7, GPBP1,
BATF3, VDR [through induction of its ligand], and NCOA1, the
nuclear hormone coactivator).
In summary, the generation of pig BMDM provides a model
system for studying macrophage functional genomics that more
closely resembles human biology than traditional mouse models.
The domestic pig also offers a potential intersection of genomics
and genetics. For example, Benga et al. (46) have reported sig-
nificant variation in the response of individuals within and be-
tween pig breeds to microbial challenge. The use of BMDM in
future studies will permit the assessment of macrophage autono-
mous variation in populations of animals from diverse sources,
separated from the influence of husbandry, nutrition, and other
variables. This in turn may contribute to understanding the genetic
control of disease susceptibility in humans.
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